Why the study?
Does recombinant human extracellular-superoxide dismutase type C reduce cardiac damage in isolated rat hearts subjected to ischemia and reperfusion?
Does recombinant human extracellular-superoxide dismutase type C reduce cardiac damage in isolated rat hearts subjected to ischemia and reperfusion?
Recombinant human extracellular-superoxide dismutase type C reduces biochemical markers of injury and preserves cardiac contractile function in a rat model of ischemia-reperfusion.
No takes yet. Share an insight, caveat, or question.
rh-EC-SOD C may protect isolated rat hearts; leaves open translation to human ischemia-reperfusion injury.
Sjöquist et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: